Zhengguang Wang Selected Research

Member 1 Group F Nuclear Receptor Subfamily 1

1/2021	RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer.
2/2017	Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhengguang Wang Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 01/2013
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2012
5	Adenocarcinoma 01/2022 - 03/2012
3	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 05/2017
3	Carcinogenesis 01/2019 - 01/2013
2	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Infertility (Sterility) 11/2020 - 01/2020
2	Hypoxia (Hypoxemia) 05/2017 - 07/2015
2	Carcinoma (Carcinomatosis) 02/2017 - 01/2016
2	Neurofibrosarcoma (MPNST) 07/2015 - 01/2013
1	Hematuria 09/2021
1	Myocardial Infarction 09/2021
1	Syncope (Fainting) 09/2021
1	Cardiac Arrhythmias (Arrythmia) 09/2021
1	Septic Shock (Toxic Shock Syndrome) 09/2021
1	Burns 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2018
1	Osteoporosis 03/2018
1	Body Weight (Weight, Body) 03/2018
1	Postmenopausal Osteoporosis 03/2018
1	Neurilemmoma (Schwannoma) 05/2017
1	Inflammation (Inflammations) 02/2017
1	Critical Illness (Critically Ill) 05/2015
1	Shock 05/2015
1	Acute Kidney Injury (Acute Renal Failure) 05/2015
1	Diabetes Mellitus 05/2015
1	Hypertension (High Blood Pressure) 05/2015
1	Neurofibroma 01/2013

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2018
3	InterleukinsIBA 01/2019 - 01/2013
3	Ephrin-A3 (Ephrin A3)IBA 05/2017 - 01/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 01/2013
2	Long Noncoding RNAIBA 01/2022 - 05/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
2	Member 1 Group F Nuclear Receptor Subfamily 1IBA 01/2021 - 02/2017
2	Caspase 3 (Caspase-3)IBA 01/2020 - 08/2018
2	AICA ribonucleotide (ZMP)IBA 02/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 09/2016 - 01/2013
2	Fluorouracil (Carac)FDA LinkGeneric 09/2016 - 01/2016
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2021
1	Member 1 Group D Nuclear Receptor Subfamily 1IBA 01/2021
1	S100A12 ProteinIBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	TensinsIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2018
1	Alkaline PhosphataseIBA 03/2018
1	Acid PhosphataseIBA 03/2018
1	Therapeutic UsesIBA 03/2018
1	OsteoprotegerinIBA 03/2018
1	icariinIBA 03/2018
1	LigandsIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2017
1	AMP-Activated Protein KinasesIBA 02/2017
1	RetinoidsIBA 02/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015
1	IntegrinsIBA 07/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2015
1	Transcription Activator-Like Effector NucleasesIBA 07/2015
1	GTP Phosphohydrolases (GTPases)IBA 07/2015
1	Starch (Cornstarch)IBA 05/2015
1	Blood Glucose (Blood Sugar)IBA 05/2015
1	HES 130-0.4IBA 05/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	CytokinesIBA 01/2013
1	SurvivinIBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	ResveratrolIBA 03/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012

Therapy/Procedure

4	Therapeutics 01/2022 - 02/2017
2	Transplantation 10/2021 - 09/2016
2	Critical Care (Surgical Intensive Care) 09/2021 - 05/2015
1	Exercise Therapy (Therapy, Exercise) 09/2021
1	Traction 09/2021
1	Central Venous Catheters 09/2021
1	Urinary Catheters 09/2021
1	Immunotherapy 01/2021
1	Ovariectomy (Oophorectomy) 03/2018
1	Gastrectomy 01/2013